Lijun Xu

11PUBLICATIONS
4CO-AUTHORS
Epidemiological modellingMedical microbiology not elsewhere classifiedMedical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 05, 2026
Sequential Organ Failure Assessment (SOFA) score and quick SOFA(qSOFA) predict 30-day mortality in patients with HIV-associated Talaromycosis: A multicenter retrospective cohort study.

|Apr 08, 2025
Voriconazole is inferior to amphotericin B deoxycholate as the initial induction therapy for HIV-associated Talaromyces marneffei fungemia: A multicenter retrospective study.

Shasha Ye, Jiaying Qin, Xingguo Miao

|Mar 10, 2025
AIDS-Associated Talaromyces marneffei Infection with Thoracic Spinal Cord Involvement Leading to Paraplegia: A Case Report and Literature Review.

Yongzheng Guo, Ying Song, Xiaorong Peng

|Jan 22, 2025
Age-specific abnormal glucose metabolism in HIV-positive people on antiviral therapy in China: a multicenter case-control study.

Lijun Xu, Mengsha Chen, Chunhui Yan

|Dec 18, 2023
Aspartate Aminotransferase/Platelet Ratio Index Upon Admission Predicts 24-Week Mortality in Patients With HIV-Associated Talaromyces marneffei.

Qi Wang, Handan Zhao, Yong Tong

|Nov 21, 2023
Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment.

Handan Zhao, Yanqiu Lu, Shan Li

Pageof 2

Frequent Collaborators

1 joint publications

Yaokai Chen

1 joint publications

Biao Zhu

1 joint publications

Qi Wang

1 joint publications

Yongzheng Guo